I am using a standalone device that tests for SARS-CoV-2 IgM and IgG antibodies at the point of care (POCT), which new code should I report? ...
Subscribe or sign in to view the full article.
Article Overview
This article is a brief coding guidance note for clinicians and coding professionals dealing with point-of-care SARS-CoV-2 testing. It addresses how the service is characterized in CPT, notes that multiple COVID-19 test modalities may be involved, and indicates that the guidance is tied to an early-pandemic code update. The content is useful for anyone selecting laboratory or pathology codes for COVID-19 testing workflows.
Why This Topic Matters
COVID-19 testing methods were rapidly evolving, and accurate code selection depended on matching the reported service to the actual test methodology. This article helps readers understand which coding area to review for point-of-care SARS-CoV-2 testing and highlights that coding should reflect the service performed.
What You Will Learn
- How point-of-care SARS-CoV-2 testing is categorized at a high level in CPT.
- The difference between antibody testing and nucleic acid analysis as general testing modalities discussed in the article.
- Why the article is relevant to early COVID-19 coding updates.
- The importance of matching coding to the service actually provided.
Who Should Read This
- Medical coders
- Billing specialists
- Laboratory professionals
- Compliance teams
- Clinicians ordering COVID-19 tests
Codes Discussed
Subscribe or sign in to view the full article.

Quick, Current, Complete - www.findacode.com